# Jed Litwiniuk

> Jed Litwiniuk, also publicly listed as Jędrzej or Jedrzej Litwiniuk, is the co-founder and CEO of Auxilius Pharma. His career includes investment roles at Enterprise Venture Fund and PZU, acquisitions leadership at LUX MED, and management of Centrum Medyczne Gamma. He earned an Executive MHA at Columbia in 2019 and founded Auxilius with classmate Uwe Tigör.

- **Role:** Co-Founder & Chief Executive Officer at Auxilius Pharma
- **Organizations:** Auxilius Pharma, LUX MED, PZU, Enterprise Venture Fund, Centrum Medyczne Gamma, Picket Pharmaceuticals, EMC Instytut Medyczny
- **Education:** Executive Master of Health Administration, Columbia University, Mailman School of Public Health, SGH Warsaw School of Economics
- **Known for:** Co-founded Auxilius Pharma in 2019., Completed an Executive MHA at Columbia University in 2019., Led Auxilius through publicly announced investment rounds and the 2026 NanoGroup integration agreement.

## Career timeline

- **Before 2019** — Held investment roles at Enterprise Venture Fund and PZU, led M&A at LUX MED, and served as CEO of Centrum Medyczne Gamma; exact employment dates not verified.
- **2014** — Appointed to the supervisory board of EMC Instytut Medyczny on May 14.
- **2017** — Resigned from the EMC supervisory board effective November 5.
- **2019** — Completed his Executive MHA at Columbia and co-founded Auxilius Pharma with Uwe Tigör.
- **2022** — Announced approximately USD 1 million of investment from CofounderZone, Augebit FIZ and business angels.
- **2025** — Auxilius announced a USD 4 million Series A in December.
- **2026** — Auxilius and NanoGroup signed an investment agreement in June; Litwiniuk was expected to join NanoGroup’s management board subject to formalities while continuing as Auxilius CEO.

## Achievements

- Co-founded Auxilius Pharma in 2019.
- Completed an Executive MHA at Columbia University in 2019.
- Led Auxilius through publicly announced investment rounds and the 2026 NanoGroup integration agreement.

## Latest updates

- **2026-06** — Auxilius and NanoGroup signed an investment agreement for a share exchange and planned integration; the announced terms envisaged Litwiniuk joining NanoGroup’s management board after required formalities.
- **2026-08** — Auxilius announced an agreement with Skyepharma, adding an external production partner.

## Links

- Website: https://auxiliuspharma.com/
- LinkedIn: https://www.linkedin.com/in/jedrzej-litwiniuk-mha-0102ab/

---

Profile page: https://yespress.io/jed-litwiniuk
Published by YesPress — https://yespress.io
Last updated: 2026-10-14